Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Ageing reversal may be closer than we think – scientists have begun human trials to test anti-ageing methods.

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Advances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science ...

A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely ...

Life Biosciences, a Boston longevity biotech co-founded by Harvard genetics professor David Sinclair, has locked down an $80 ...

Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice ...

HexemBio has launched with a seed round led by Draper Associates to advance a blood stem cell rejuvenation therapy backed by Robert Langer.

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the close of a ...